James Troy, MD



Dr. Troy has been affiliated with the MCW Department of Dermatology since 1980.  A native of Des Moines, Dr. Troy graduated from Harvard College and Harvard Medical School, completed residencies in internal medicine and dermatology at Columbia-Presbyterian in New York City, and was a dermatopathology fellow with Dr. A. Bernard Ackerman at New York University.

Dr. Troy practiced clinical dermatology on and off campus until 2008 when he devoted his entire professional effort to dermatopathology. He served as director of the inpatient service and co-director of the pigmented lesion clinic at MCW, he was named several times to the Best Doctors in America list, and he has been president of the Wisconsin Dermatological Society. He established an independent laboratory of dermatopathology in 1990 and uses the volume of cases from that facility to teach residents both in conferences and in one-on-one sign-out sessions.

Dr. Troy has been co-author of one book, several chapters, and numerous peer-reviewed publications. Since 2009, he has been a member of the scientific advisory team for Roche in the successful development of vemurafenib for the treatment of metastatic melanoma, lecturing at numerous national and international clinical investigator meetings.

James Troy, MD
James Troy, MD

Board Certification(s)

  • Internal Medicine
  • Dermatology
  • Dermatopathology

Languages Spoken

  • English

Education / Training

  • MD – Harvard Medical School (1975)
  • Residency – Internal Medicine, Columbia-Presbyterian Medical Center (1978)
  • Residency – Dermatology, Columbia-Presbyterian Medical Center (1980)
  • Fellowship – Dermatopathology, New York University Medical Center (1981)

In the News